This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview
Zingg, Daniel

Daniel Zingg



In 2009, I achieved my Master's degree in Cell Biology at the Swiss Federal Institute of Technology (ETH) Zurich, Switzerland. In the course of my PhD in the lab of Lukas Sommer at the University of Zurich, Switzerland (2010-2015), I investigated the relevance of the epigenetic modifier EZH2 for cutaneous melanoma initiation and metastatic progression. Consequently, I became interested in the role of the primary cilium during melanoma initiation, which I pursued investigating as postdoctoral fellow in the Sommer lab.

In 2018, I joined the lab of Jos Jonkers as postdoctoral fellow to study molecular mechanisms contributing to the initiation of invasive lobular breast cancer using genome-wide forward genetic screening in murine mammary epithelial cells and genetically engineered mouse models.